South Korean startup Divine Technology, which develops performance validation solutions for medical devices and Software Defined Vehicle (SDV) applications, has secured seed investment from Genaxis.

Divine Technology is developing an AI– and simulation-based platform that supports performance testing of medical device valves and stents, as well as simulators that validate the safety of autonomous vehicles and ADAS systems in virtual environments using the Unreal Engine. The company is also building a simulation platform for testing AUTOSAR-standard SDV applications.

In the medical field, the company has developed complication prediction software for high-risk procedures such as Transcatheter Aortic Valve Replacement (TAVR), which can be utilized by medical device manufacturers and hospitals. In the mobility sector, its solutions support not only ADAS and autonomous driving systems but also SDV application testing.

Divine Technology has been recognized for its technical expertise by participating in major government R&D initiatives, including the Ministry of Health and Welfare’s Medical Twin Technology Development Project and the Ministry of Trade, Industry and Energy’s Autonomous Driving Technology Development and Innovation Project. The company holds one registered patent and three pending applications, and was selected for the “Super-Gap Startup 1000+” program. Additionally, partnerships with global and domestic industry leaders such as Ansys, rFpro, and TaeWoong Medical have further enhanced its technological credibility.A Genaxis representative commented, “Divine Technology demonstrates strong potential to replace conventional experiment-based validation with AI and simulation technologies across both medical and mobility sectors. We will actively support the company in securing global competitiveness in the CM&S (Computer Modeling & Simulation) domain.”